BIOMAT Database Logo BIOMAT Database Logo

Development of a fluorescence-based HIV-1 integrase DNA binding assay for identification of novel HIV-1 integrase inhibitors. 2013

Ying-Shan Han, and Wei-Lie Xiao, and Peter K Quashie, and Thibault Mesplède, and Hongtao Xu, and Eric Deprez, and Olivier Delelis, and Jian-Xin Pu, and Han-Dong Sun, and Mark A Wainberg
McGill University AIDS Centre, Lady Davis for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Human immunodeficiency virus integrase (HIV-1 IN) inhibitors that are currently approved or are in advanced clinical trials specifically target the strand transfer step of integration. However, considerable cross-resistance exists among some members of this class of IN inhibitors. Intriguingly, though, HIV-1 IN possesses multiple sites, distinct from those involved in the strand transfer step, that could be targeted to develop new HIV-1 IN inhibitors. We have developed a fluorescent HIV-1 IN DNA binding assay that can identify small molecules termed IN binding inhibitors (INBIs) that inhibit IN binding to viral DNA. This assay has been optimized with respect to concentrations of each protein, long terminal repeat (LTR) DNA substrate, salt, and time, and has been used successfully to measure the HIV-1 IN DNA binding activity of a well-characterized INBI termed FZ41. In addition, we have used the assay to screen a small library of natural products, resulting in the identification of nigranoic acid as a new INBI. The proposed fluorescence assay is easy and inexpensive, and provides a high-throughput detection method for determination of HIV-1 IN DNA binding activity, monitoring of enzyme kinetics, and high-throughput screening for the identification of new INBIs.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005453 Fluorescence The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D012717 Sesquiterpenes Fifteen-carbon compounds formed from three isoprenoid units with general formula C15H24. Farnesanes,Farnesene,Farnesenes,Sesquiterpene,Sesquiterpene Derivatives,Sesquiterpenoid,Sesquiterpenoids,Derivatives, Sesquiterpene
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

Ying-Shan Han, and Wei-Lie Xiao, and Peter K Quashie, and Thibault Mesplède, and Hongtao Xu, and Eric Deprez, and Olivier Delelis, and Jian-Xin Pu, and Han-Dong Sun, and Mark A Wainberg
Development of an AlphaScreen-based HIV-1 integrase dimerization assay for discovery of novel allosteric inhibitors.
June 2012, Journal of biomolecular screening,
Ying-Shan Han, and Wei-Lie Xiao, and Peter K Quashie, and Thibault Mesplède, and Hongtao Xu, and Eric Deprez, and Olivier Delelis, and Jian-Xin Pu, and Han-Dong Sun, and Mark A Wainberg
Development of a phenotypic susceptibility assay for HIV-1 integrase inhibitors.
December 2016, Journal of virological methods,
Ying-Shan Han, and Wei-Lie Xiao, and Peter K Quashie, and Thibault Mesplède, and Hongtao Xu, and Eric Deprez, and Olivier Delelis, and Jian-Xin Pu, and Han-Dong Sun, and Mark A Wainberg
Hairpin DNA probe-based fluorescence assay for detecting palindrome cleavage activity of HIV-1 integrase.
September 2014, Analytical biochemistry,
Ying-Shan Han, and Wei-Lie Xiao, and Peter K Quashie, and Thibault Mesplède, and Hongtao Xu, and Eric Deprez, and Olivier Delelis, and Jian-Xin Pu, and Han-Dong Sun, and Mark A Wainberg
Novel 3'-Processing Integrase Activity Assay by Real-Time PCR for Screening and Identification of HIV-1 Integrase Inhibitors.
January 2015, BioMed research international,
Ying-Shan Han, and Wei-Lie Xiao, and Peter K Quashie, and Thibault Mesplède, and Hongtao Xu, and Eric Deprez, and Olivier Delelis, and Jian-Xin Pu, and Han-Dong Sun, and Mark A Wainberg
A novel assay for the DNA strand-transfer reaction of HIV-1 integrase.
March 1994, Nucleic acids research,
Ying-Shan Han, and Wei-Lie Xiao, and Peter K Quashie, and Thibault Mesplède, and Hongtao Xu, and Eric Deprez, and Olivier Delelis, and Jian-Xin Pu, and Han-Dong Sun, and Mark A Wainberg
Synthesis of novel thiazolothiazepine based HIV-1 integrase inhibitors.
August 2004, Bioorganic & medicinal chemistry,
Ying-Shan Han, and Wei-Lie Xiao, and Peter K Quashie, and Thibault Mesplède, and Hongtao Xu, and Eric Deprez, and Olivier Delelis, and Jian-Xin Pu, and Han-Dong Sun, and Mark A Wainberg
Development of an oligonucleotide-based fluorescence assay for the identification of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors.
June 2014, Analytical biochemistry,
Ying-Shan Han, and Wei-Lie Xiao, and Peter K Quashie, and Thibault Mesplède, and Hongtao Xu, and Eric Deprez, and Olivier Delelis, and Jian-Xin Pu, and Han-Dong Sun, and Mark A Wainberg
Binding modes of two novel dinucleotide inhibitors of HIV-1 integrase.
August 2002, Bioorganic & medicinal chemistry letters,
Ying-Shan Han, and Wei-Lie Xiao, and Peter K Quashie, and Thibault Mesplède, and Hongtao Xu, and Eric Deprez, and Olivier Delelis, and Jian-Xin Pu, and Han-Dong Sun, and Mark A Wainberg
Dynamic pharmacophore model optimization: identification of novel HIV-1 integrase inhibitors.
March 2006, Journal of medicinal chemistry,
Ying-Shan Han, and Wei-Lie Xiao, and Peter K Quashie, and Thibault Mesplède, and Hongtao Xu, and Eric Deprez, and Olivier Delelis, and Jian-Xin Pu, and Han-Dong Sun, and Mark A Wainberg
[Computer search for novel HIV-1 integrase inhibitors].
January 2005, Biomeditsinskaia khimiia,
Copied contents to your clipboard!